Relmada Therapeutics
RLMD
#9903
Rank
C$16.48 M
Marketcap
$0.55
Share price
4.60%
Change (1 day)
-87.43%
Change (1 year)

Relmada Therapeutics (RLMD) - Cash on Hand

Cash on Hand as of September 2024 : C$77.91 Million

According to Relmada Therapeutics's latest financial reports the company has C$77.91 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Relmada Therapeutics - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31C$0.20 B-25.48%
2021-12-31C$0.27 B80.89%
2020-12-31C$0.14 B
2019-06-30C$12.09 M310.9%
2018-06-30C$2.94 M32.47%
2017-06-30C$2.22 M-79.79%
2016-06-30C$10.99 M-60.58%
2015-06-30C$27.88 M2.29%
2014-06-30C$27.26 M
2013-08-31C$0.01 M81.06%
2012-08-31C$0 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$1.29 B 1,567.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
C$1.45 B 1,769.43%๐Ÿ‡บ๐Ÿ‡ธ USA